K-numberK260245
Device nameSILKBridge
ApplicantKLISBio S.r.l.
Product codeJXI
Device classClass II
Decision dateApr 9, 2026
DecisionSubstantially Equivalent
Regulation882.5275
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

SILKBridge is a bioabsorbable silk fibroin-based nerve guide (cuff) designed for surgical repair of peripheral nerve gaps up to 10 mm. It is a hollow tubular implant with semi-permeable, non-constrictive walls that guide axonal growth, protect the injured nerve, and allow nutrient influx while the implant is enzymatically absorbed as native tissue regenerates.

Technological characteristics

SILKBridge uses silk fibroin (Bombyx mori) in a three-layer wall design (native fiber textile intermediate layer, electrospun inner and outer layers) totaling up to 24 mg, whereas the predicate Neurolac TW uses a single homogenous poly(DL-lactide-co-ε-caprolactone) layer. Both are semi-permeable, non-constrictive bioabsorbable nerve guides with comparable mechanical properties and the same intended use.

Test standards cited

ISO 10993-1 (biocompatibility framework), ISO 10993-5 (cytotoxicity), ISO 10993-23 (intracutaneous reactivity), ISO 10993-10 (sensitization), ISO 10993-11 (acute systemic toxicity and pyrogenicity), ISO 10993-4/ASTM F619/F756 (hemolysis), ISO 10993-6 (implantation), ISO 10993-17 and ISO 10993-18 (chemical characterization and toxicological risk assessment), and ASTM standards for mechanical properties.

Substantial equivalence argument

SILKBridge is substantially equivalent to Neurolac TW Nerve Guide because both share the same intended use, indications (repair of peripheral nerve discontinuities ≤10 mm), operating principle, and fundamental technology. Minor differences in wall design and material do not raise new safety or effectiveness questions; biocompatibility testing confirms biological safety per ISO 10993-1, bench testing demonstrates comparable mechanical properties, and 12-month rat sciatic nerve injury studies show equivalent safety and functional recovery.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →